News | Nov 14/18

Congratulations to all the start-ups selected to participate in the 2018 Innovacorp Accelerate Program and Start-Up Yard at COVE cohorts.

INNOVACORP ACCELERATE PROGRAM                          

Award Highlights: $50,000 and business guidance to address key technical and business milestones, along with access to incubation space at Innovacorp’s facilities

News | Oct 15/18

Patron Technology, an industry-leading live event technology company, announced today it has acquired Marcato, a global provider of event logistics software. Marcato will continue to service its clients with innovative technology as the company becomes integrated into the growing Patron Technology platform. The terms of the transaction were not disclosed.

Paper Chasin | Oct 3/18

This article was written by Michael Bochoff, Marketing & Communications Assistant at Innovacorp.

News | Sep 26/18

CarbonCure Technologies Inc. announced today that it has closed a strategic round of investment led by Breakthrough Energy Ventures, one of the world’s most sought-after clean technology investment partners. 

News | Sep 12/18

Wagner among 22 recipients from six continents to be recognized for her role in “taking ambition to the next level” as part of this week’s Global Climate Action Summit in San Francisco

News | Sep 7/18

Creativity and innovation were on the minds of many this morning as they gathered to celebrate the grand opening of the Nova Scotia Power Makerspace at the New Dawn Centre for Social Innovation in Sydney.  

Paper Chasin | Sep 5/18

This article was written by Michael Bochoff, Marketing & Communications Assistant at Innovacorp.

News | Aug 21/18

CarbonCure Technologies is pleased to announce an expanded partnership with Central Concrete Supply Co., Inc. (“Central Concrete”), a northern California business unit of U.S. Concrete, Inc. (NASDAQ:USCR).

Paper Chasin | Aug 8/18

The following post was written by Lyuba Golovina, marketing manager at Skaled.

News | Jul 30/18

ABK Biomedical Inc., a company dedicated to the research, development and commercialization of innovative embolic therapies, has announced the appointment of Michael J. Mangano as president and CEO.